TORONTO — Olympic officials made the right call in postponing the Canada-Finland women's hockey game on Thursday after ...
The MarketWatch News Department was not involved in the creation of this content.-- Novo Nordisk's first big game spot introduces America to the FDA-approved Wegovy(R) pill -- the ...
Daniel Kirby, Chief Commercial Officer of Iovance, stated, "The real world Amtagvi data with impressive response rates, paired with unprecedented five-year durability and survival data, demonstrate a ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...
Patients with advanced melanoma experienced high response rates when treated with commercial Amtagvi in a real-world clinical ...
At least three people have died and three others have required liver transplants after eating the aptly named Death Cap mushroom that is proliferating in California following a ...
Novo Nordisk's first big game spot introduces America to the FDA-approved Wegovy® pill — the first and only GLP-1 pill for ...
Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...